Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease. Devanarayan V, Doherty T, Charil A, Sachdev P, et al. Alzheimers Dement 2024 Jun 28. doi: 10.1002/alz.14073.

Read + Share

Amedeo Smart

Independent Medical Education

Devanarayan V, Doherty T, Charil A, Sachdev P, et al. Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease. Alzheimers Dement 2024 Jun 28. doi: 10.1002/alz.14073.
PMID: 38940656